| scholarly article | Q13442814 |
| P2093 | author name string | Luis Mauricio Hurtado-López | |
| Abel Jalife-Montaño | |||
| Alejandro Ortiz-Covarrubias | |||
| Abraham Pulido-Cejudo | |||
| Héctor Faustino Noyola-Villalobos | |||
| Jose Luis Martínez-Ordaz | |||
| Mario Guzmán-Gutierrez | |||
| P2860 | cites work | Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America | Q88172637 |
| Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic | Q24614464 | ||
| Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe | Q26747252 | ||
| Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China | Q26749179 | ||
| Implementing criteria-based early switch/early discharge programmes: a European perspective | Q26801251 | ||
| Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections | Q26801257 | ||
| European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid | Q26823518 | ||
| Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines | Q26829316 | ||
| Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study | Q28384260 | ||
| Predicting observation unit treatment failures in patients with skin and soft tissue infections | Q28387876 | ||
| Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs | Q30251580 | ||
| New epidemiology of Staphylococcus aureus infection in Asia. | Q30363143 | ||
| The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom | Q31629893 | ||
| Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study | Q33519083 | ||
| Skin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based study | Q33595221 | ||
| Risk factors for erysipelas of the leg (cellulitis): case-control study. | Q33620263 | ||
| Trends in US hospital admissions for skin and soft tissue infections | Q33644594 | ||
| First report of infection with community-acquired methicillin-resistant Staphylococcus aureus in South America | Q33753213 | ||
| Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review | Q34018759 | ||
| Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children | Q34157657 | ||
| Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. | Q34245820 | ||
| Characterization of community acquired Staphylococcus aureus associated with skin and soft tissue infection in Beijing: high prevalence of PVL+ ST398. | Q34305562 | ||
| Once-weekly dalbavancin versus daily conventional therapy for skin infection | Q34422888 | ||
| Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America | Q34425750 | ||
| World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections | Q34565950 | ||
| Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S. | Q34672631 | ||
| Strategies to prevent surgical site infections in acute care hospitals: 2014 update | Q34712478 | ||
| Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
| Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists | Q34910366 | ||
| Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection | Q35017990 | ||
| Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study | Q35155399 | ||
| Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study | Q35671893 | ||
| Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases | Q43541559 | ||
| An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska | Q44163434 | ||
| Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection | Q44320945 | ||
| Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study | Q44469241 | ||
| Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections | Q44958309 | ||
| High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity | Q45302930 | ||
| Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. | Q45999362 | ||
| Risk stratification and outcome of cellulitis admitted to hospital | Q46178540 | ||
| Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). | Q46805282 | ||
| Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department | Q55897489 | ||
| Recurrent erysipelas: Predisposing factors and costs of prophylaxis | Q56093945 | ||
| Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis | Q60647959 | ||
| Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study | Q61962398 | ||
| Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study | Q64128667 | ||
| Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee | Q64132021 | ||
| Quantitative cultures of biopsy specimens from cutaneous cellulitis | Q69485327 | ||
| Erysipelas: clinical and bacteriologic spectrum and serological aspects | Q71786862 | ||
| Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome | Q79784288 | ||
| Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009 | Q83215855 | ||
| Skin and soft tissue infections | Q83467771 | ||
| Diagnosing and managing lower limb cellulitis | Q84720818 | ||
| Clinical practice guidelines for antimicrobial prophylaxis in surgery | Q85911799 | ||
| Acute Bacterial Skin and Skin Structure Infections Treated with Intravenous Antibiotics in the Emergency Department or Observational Unit: Experience at the Detroit Medical Center. | Q35752774 | ||
| Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay | Q36009430 | ||
| Sternal Wound Infection after Cardiac Surgery: Management and Outcome | Q36108757 | ||
| Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients | Q36207015 | ||
| Simplified risk stratification criteria for identification of patients with MRSA bacteremia at low risk of infective endocarditis: implications for avoiding routine transesophageal echocardiography in MRSA bacteremia. | Q36494439 | ||
| A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection | Q36543866 | ||
| Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia | Q36836505 | ||
| Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections | Q36887908 | ||
| Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature | Q36930855 | ||
| In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study | Q37263425 | ||
| A prospective observational cohort study in primary care practices to identify factors associated with treatment failure in Staphylococcus aureus skin and soft tissue infections | Q37431852 | ||
| Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America | Q37455462 | ||
| Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study. | Q37473469 | ||
| Soft tissue infections and emergency department disposition: predicting the need for inpatient admission | Q37669428 | ||
| Complicated skin and soft tissue infection | Q37793714 | ||
| New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good | Q37872515 | ||
| Skin and soft tissue infections: the new surgical infection society guidelines | Q37902233 | ||
| Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature | Q37978658 | ||
| The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. | Q37981103 | ||
| Blood culture results do not affect treatment in complicated cellulitis | Q38099176 | ||
| European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid | Q38192097 | ||
| Daptomycin and Its Immunomodulatory Effect: Consequences for Antibiotic Treatment of Methicillin-Resistant Staphylococcus aureus Wound Infections after Heart Surgery | Q38198019 | ||
| Hospitalist perspective on the treatment of skin and soft tissue infections | Q38224127 | ||
| Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital | Q38326042 | ||
| Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial | Q38456150 | ||
| Incidence and factors associated with emergency department visits for recurrent skin and soft tissue infections in patients in California, 2005-2011. | Q38787222 | ||
| Elderly patients are at increased risk for treatment failure in outpatient management of purulent skin infections | Q39194718 | ||
| Transitions of care in the management of acute bacterial skin and skin structure infections: a paradigm shift | Q39719043 | ||
| Two unusual cases of severe soft tissue infection caused by Streptococcus dysgalactiae subsp. equisimilis | Q39900875 | ||
| Failure of outpatient antibiotics among patients hospitalized for acute bacterial skin infections: What is the clinical relevance? | Q40115127 | ||
| Failure of Emergency Department Observation Unit Treatment for Skin and Soft Tissue Infections | Q40157578 | ||
| Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors | Q40179605 | ||
| Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study | Q40187951 | ||
| Single-dose oritavancin in the treatment of acute bacterial skin infections. | Q40204783 | ||
| Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis. | Q40206676 | ||
| Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus | Q40216245 | ||
| Identifying patients with cellulitis who are likely to require inpatient admission after a stay in an ED observation unit | Q40267827 | ||
| In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program | Q40390434 | ||
| Management of non-necrotizing cellulitis in France | Q40654407 | ||
| New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections | Q40678676 | ||
| Skin and soft-tissue infections: Factors associated with mortality and re-admissions. | Q40721598 | ||
| Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance-a retrospective population based study from Finland and Sweden | Q40819884 | ||
| In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program | Q40976207 | ||
| Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial | Q42211543 | ||
| Initial treatment failure in patients with complicated skin and skin structure infections | Q42266507 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 143-161 | |
| P577 | publication date | 2017-08-31 | |
| P1433 | published in | Therapeutic advances in infectious disease | Q26842293 |
| P1476 | title | Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure | |
| P478 | volume | 4 |
| Q64066297 | Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections |
| Q57158658 | Antibiotic therapy for skin and soft tissue infections: a protocol for a systematic review and network meta-analysis |
| Q89017754 | Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey |
| Q89604893 | Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries |
| Q91733655 | Diagnostic Stewardship: A Clinical Decision Rule for Blood Cultures in Community-Onset Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections |
| Q92921231 | Early discharge criteria in patients with acute bacterial skin and skin structure infections in a large tertiary-care teaching hospital in Florence, Italy |
| Q91823313 | In Vitro Activity and Microbiological Efficacy of Gepotidacin from a Phase 2, Randomized, Multicenter, Dose-Ranging Study in Patients with Acute Bacterial Skin and Skin Structure Infections |
| Q92327631 | Omadacycline for Acute Bacterial Skin and Skin Structure Infections |
| Q59882686 | Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series |
| Q92772525 | Susceptibility of microorganisms causing acute hand infections |
Search more.